Sort
78,016 grants matching “breast cancer”
TARGETING MIR551B TO PREVENT TUMOR FORMATION AND METASTASIS OF TRIPLE-NEGATIVE BREAST CANCER
$562,697The Medical College Of Wisconsin, Inc. · · FY2018 · Department of the Army
TARGETING THE ATR PATHWAY AS A MEANS TO TREAT P53-DEFICIENT BREAST CANCERS
$562,692Trustees Of The University Of Pennsylvania, The · · FY2009 · Department of the Army
Planning and Evaluation Core
$562,676Clement K. Gwede · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2020 · CA
Mapping the regulatory landscape of RNA binding proteins and their causal roles in tumorigenesis and patient survival
$562,675Saeed F Tavazoie · Columbia University Health Sciences · R01 · FY2021 · CA
Mammographic Density & Prognosis among Breast Cancer Intrinsic Subtypes
$562,665Laurel A Habel · Kaiser Foundation Research Institute · R01 · FY2012 · CA
Computational Approaches for RNA Structure and Function Determination
$562,649Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Western Regional Community Clinical Oncology Program
$562,644Banner Good Samaritan Medical Center · U10 · FY2004 · CA
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
$562,599Thomas E Seay · St. Joseph'S Hospital · U10 · FY2012 · CA
SOY AND ESTROGEN INTERACTIONS IN THE BREAST
$562,583J. Mark Cline · Wake Forest University Health Sciences · R01 · FY2009 · AT
Building upon a tradition of excellence. The NCTN at Indiana University
$562,579Kathy D Miller · Indiana University Indianapolis · U10 · FY2018 · CA
Methods for Etiologic Studies of Diet and Cancer
$562,570Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
NOVEL BIOMARKERS FOR AROMATASE INHIBITOR THERAPY
$562,544Matthew J Ellis · Washington University · R01 · FY2010 · CA
Targeted Core Shell Nanogels for Triple Negative Breast Cancer
$562,542Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U01 · FY2016 · CA
Targeted Core Shell Nanogels for Triple Negative Breast Cancer
$562,542Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U01 · FY2017 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2022 · CA
Targeted Core Shell Nanogels for Triple Negative Breast Cancer
$562,533Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U01 · FY2018 · CA
A BREAST CANCER TARGET
$562,500University Of Maryland, Baltimore · · FY2009 · Department of the Army
REDUCING BREAST CANCER MORTALITY PROGRAM (BRRP) IDEA AWARD
$562,500University Of Maryland, Baltimore · · FY2009 · Department of the Army
HOMOCYSTEINE IS AN ONCOMETABOLITE IN BREAST CANCER, WHICH PROMOTES TUMOR PROGRESSION AND METASTASIS
$562,500Texas Tech University Health Sciences Center · · FY2013 · Department of Defense
EXTRACELLULAR VESICLE-BASED NON-INVASIVE DETECTION OF PIK3CA COMPOUND MUTATION FOR BREAST CANCER
$562,500Captis Diagnostics Inc. · · FY2022 · Defense Health Agency
Defining the Functions of Entero-Mammary T cells in Lactogenesis and Maternal-Offspring Immunity
$562,500Deepshika Ramanan · Salk Institute For Biological Studies · DP2 · FY2025 · AI
CTCF-mediated regulation of partial epithelial-mesenchymal transition states
$562,499Joseph H. Taube · Baylor University · R15 · FY2025 · GM
P53, DNA Repair Imbalance, and Immune Response in Breast Cancer Mortality Disparities
$562,462Melissa A. Troester · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Modeling response to P13K Target Therapies
$562,459Gordon B. Mills · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2010 · CA